ETON
NASDAQ · Pharmaceuticals
Eton Pharmaceuticals Inc
$34.95
+0.97 (+2.85%)
Open$34.12
Previous Close$33.98
Day High$34.98
Day Low$33.93
52W High$35.66
52W Low$13.09
Volume—
Avg Volume310.1K
Market Cap889.70M
P/E Ratio—
EPS$-0.06
SectorPharmaceuticals
Analyst Ratings
Strong Buy
9 analysts
Price Target
-65.9% upside
Current
$34.95
$34.95
Target
$11.93
$11.93
$8.04
$11.93 avg
$13.91
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 81.79M | 52.59M | 122.17M |
| Net Income | -4,707,281 | -2,723,945 | 16.25M |
| Profit Margin | -5.8% | -5.5% | 13.3% |
| EBITDA | 3.27M | 2.00M | 25.36M |
| Free Cash Flow | — | — | 11.15M |
| Rev Growth | +55.5% | +55.5% | -8.5% |
| Debt/Equity | 1.17 | 1.17 | 0.20 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,124.85 | +0.68% | 40.9 | 1.03T |
| JNJ | Johnson & Johnson | $245.14 | +1.72% | 26.1 | 549.78B |
| MRK | Merck & Co. Inc. | $124.71 | +3.41% | 31.5 | 281.24B |
| PFE | Pfizer Inc. | $23.83 | -0.87% | 19.2 | 143.68B |
| BMY | Bristol-Myers Squibb Co | $55.00 | -0.95% | 18.5 | 110.27B |
| ZTS | Zoetis Inc | $77.65 | -0.67% | 12.5 | 33.00B |